Model systems: Mechanisms involved in the loss of sensitivity to letrozole

This publication has 15 references indexed in Scilit:

• Additive Antitumor Effect of Aromatase Inhibitor Letrozole and Antiestrogen Fulvestrant in a Postmenopausal Breast Cancer Model
  Cancer Research, 2005
• Effects of Exemestane and Tamoxifen in a Postmenopausal Breast Cancer Model
  Clinical Cancer Research, 2004
• Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer
  JNCI Journal of the National Cancer Institute, 2004
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Laboratory models of breast and endometrial cancer to develop strategies for antiestrogen therapy
  Breast Cancer, 1998
• Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers
  Endocrinology, 1996
• Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats
  The Journal of Steroid Biochemistry and Molecular Biology, 1993
• Studies on the mechanism of estrogen biosynthesis in the rat ovary–I
  The Journal of Steroid Biochemistry and Molecular Biology, 1976
• A Multiple Comparison Procedure for Comparing Several Treatments with a Control
  Journal of the American Statistical Association, 1955